Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.
TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Recalled by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company Due to Chemical Contamination; presence of benzene.
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company directly.
Affected Products
TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591 UPC 3 63736 81961 3
Quantity: 59,644 cans
Why Was This Recalled?
Chemical Contamination; presence of benzene.
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company has 2 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report